Patents Assigned to FBM THERAPEUTICS, LLC
  • Patent number: 9938289
    Abstract: The present invention provides for compounds of Formula I, and pharmaceutically acceptable salts thereof, wherein R1, R2, R3, R4, R5, R6, and R7 have any of the values defined therefor in the specification, and pharmaceutically acceptable salts thereof, that are useful as therapeutic agents in the treatment of TGF?-mediated conditions, including cancer and fibrotic disorders. Also provided are pharmaceutical compositions comprising one or more compounds of Formula I.
    Type: Grant
    Filed: January 14, 2016
    Date of Patent: April 10, 2018
    Assignee: FBM THERAPEUTICS, LLC
    Inventors: Stephen D. Barrett, James B. Kramer, Mark L. Boys, Huifen Chen